A type I IFN, prothrombotic hyperinflammatory neutrophil signature is distinct for COVID-19 ARDS (2021)
Attributed to:
Phase 1 COVID-19 Immunity - National Core Study
funded by
COVID
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.12688/wellcomeopenres.16584.1
Publication URI: http://dx.doi.org/10.12688/wellcomeopenres.16584.1
Type: Journal Article/Review
Parent Publication: Wellcome Open Research